Fatty Liver Is Now Called MASLD: What Chennai Patients Should Know About This Growing Metabolic Problem
- 6 days ago
- 5 min read

Fatty Liver Is Now Called MASLD: Why the Name Change Matters
If an ultrasound report says fatty liver, many people do not take it seriously.
Common reactions include:
"I don't drink alcohol, so why do I have fatty liver?"
"Everyone seems to have Grade 1 fatty liver."
"My liver enzymes are normal, so I don't need treatment."
But our understanding of fatty liver disease has changed substantially.
The condition previously known as NAFLD, or non-alcoholic fatty liver disease, is now increasingly called Metabolic Dysfunction-Associated Steatotic Liver Disease, or MASLD.
The name reflects an important reality:
For many people, fatty liver is closely connected to metabolic health.
What Is MASLD?
MASLD refers to excessive fat accumulation in the liver in the context of metabolic risk.
It is frequently associated with conditions such as:
● Overweight or obesity
● Type 2 diabetes
● Insulin resistance
● High triglycerides
● High blood pressure
● Abnormal cholesterol
● Increased abdominal fat
This is why simply telling someone to "avoid oily food" may not adequately address the problem.
Liver fat is often part of a wider metabolic pattern.
Can You Have Fatty Liver Without Drinking Alcohol?
Yes.
This is one of the most common misconceptions.
Alcohol can certainly cause liver disease, but metabolic fatty liver can occur in people who drink little or no alcohol.
In fact, the change from NAFLD to MASLD partly reflects the desire to describe the underlying metabolic problem rather than defining the disease by the absence of alcohol use.
Therefore, someone who does not drink should not assume an ultrasound finding of fatty liver is harmless.
Does Grade 1 Fatty Liver Need Treatment?
Mild fat accumulation does not necessarily mean severe liver disease.
But it should not automatically be ignored.
The bigger question is whether the liver has developed inflammation or fibrosis, meaning scarring.
Some people may have significant liver fat with little scarring.
Others can progress toward more advanced disease.
The purpose of evaluation is to identify which patients are at greater risk.
Current MASLD guidelines increasingly emphasize risk stratification, including non-invasive assessment of fibrosis rather than relying only on ultrasound.
Why Normal Liver Enzymes Don't Always Tell the Whole Story
Patients frequently focus on ALT and AST.
These blood tests are useful, but they are not perfect markers of disease severity.
A patient may have metabolic liver disease even when liver enzymes are not dramatically elevated.
That is why assessment can involve a combination of:
Medical history.
Blood tests.
Ultrasound.
Metabolic risk factors.
Fibrosis scores.
Elastography or other investigations when appropriate.
Your gastroenterologist may recommend additional evaluation depending on individual risk.
What Is Liver Fibrosis?
Fibrosis means the liver has developed scar tissue.
This is more important than simply asking how much fat is visible on an ultrasound.
The progression can broadly move from liver fat accumulation toward inflammation, fibrosis and, in a smaller proportion of patients, advanced liver damage.
Not everyone progresses.
That is precisely why identifying higher-risk individuals matters.
Modern research is also exploring machine-learning approaches to improve non-invasive detection of advanced fibrosis, illustrating how rapidly MASLD assessment is developing.
Why Are Diabetes and Fatty Liver So Closely Connected?
Type 2 diabetes and MASLD often occur together because both are strongly related to insulin resistance and metabolic dysfunction.
A person may therefore have:
High blood glucose.
High triglycerides.
Abdominal obesity.
High blood pressure.
Fatty liver.
Rather than treating these as five completely separate problems, modern medicine increasingly recognizes their connections.
This is why patients with diabetes and obesity may require closer evaluation for liver disease.
Can Lean People Develop Fatty Liver?
Yes.
Although obesity is an important risk factor, someone does not need to appear overweight to develop MASLD.
Visceral fat, genetic factors, dietary patterns, insulin resistance and other metabolic factors can influence risk.
A person who looks slim externally may still have metabolic abnormalities.
So appearance alone should not be used to judge liver health.
What Symptoms Does Fatty Liver Cause?
Many people have no symptoms.
Others may experience vague problems such as:
Fatigue.
General discomfort.
A sensation of heaviness in the upper abdomen.
But these are non-specific.
Fatty liver is therefore commonly discovered incidentally during an ultrasound performed for another reason or during a health check.
Advanced liver disease can produce much more serious symptoms, but the goal is to identify risk well before that stage.
Can Fatty Liver Be Reversed?
In earlier stages, liver fat can often improve substantially when underlying metabolic factors are addressed.
Weight management is one of the most important strategies for appropriate patients.
The American Association for the Study of Liver Diseases notes that approximately 5% to 10% weight loss can improve liver fat accumulation, inflammation and fibrosis, although individual targets vary.
This does not mean following a crash diet.
Long-term treatment typically focuses on sustainable metabolic improvement.
What Should You Eat for Fatty Liver?
There is no single "fatty liver detox diet."
Patients generally benefit from improving the overall quality of their eating pattern.
This may involve reducing:
Sugary drinks.
Highly refined carbohydrates.
Excess calorie intake.
Frequent ultra-processed foods.
Excess alcohol.
And increasing appropriate intake of:
Vegetables.
Whole foods.
Fibre.
Protein.
Healthy fats.
Portions should also match the person's metabolic goals.
Is Exercise Helpful Even Without Major Weight Loss?
Yes.
Physical activity has metabolic benefits beyond the number on the weighing scale.
A combination of aerobic activity and resistance exercise may be appropriate depending on individual health.
Sitting for long periods should also be addressed.
Someone who walks for 30 minutes but remains sedentary for the rest of the day may still have room to improve overall activity.
Are There Medicines for MASLD?
Treatment is evolving rapidly.
For many patients, managing obesity, diabetes, cholesterol and blood pressure remains central.
Specific pharmacological options may also be considered for selected patients with more advanced forms of disease.
AASLD noted in 2025 that resmetirom had become an approved pharmacological option in the United States for certain patients with fibrosis, while additional therapies continue to be studied.
Availability, regulatory approval and suitability vary by country and patient, so treatment decisions should be made with a gastroenterologist or hepatology specialist.
When Should You See a Gastroenterologist?
Consider evaluation if:
● Ultrasound repeatedly shows fatty liver
● Liver enzymes remain elevated
● You have diabetes or obesity
● You have high triglycerides
● There is a family history of liver disease
● Fibrosis scores are abnormal
● You consume alcohol regularly
● You have persistent unexplained liver-test abnormalities
The goal is to distinguish low-risk fatty liver from disease requiring closer follow-up.
Fatty Liver and Gastroenterology Care at Hycare Hospitals
At Hycare Hospitals, Chennai, patients with fatty liver can be assessed not simply based on whether an ultrasound says "Grade 1" or "Grade 2," but in the wider context of liver health and metabolic risk.
The terminology may have changed from NAFLD to MASLD.
The more important change is how we think about the disease.
Fatty liver is not simply fat sitting inside the liver. It may be a visible sign of a much larger metabolic problem.
Finding it early creates an opportunity to address both liver health and the conditions driving it






Comments